Repligen | RGEN - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 11.2B 2.13B 2025-12
Bio Techne USD 9.16B 502M 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Henry Schein USD 10.58B 1.61B 2026-03
Illumina USD 20.62B 6.53B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Mettler Toledo International USD 25.68B 2.8B 2026-03
Myriad Genetics USD 417M 158M 2026-03
OraSure Technologies USD 219M 45M 2026-03
Pacific Biosciences Of California USD 356M 209M 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Standard Biotools USD 357M 135M 2026-03
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Waters USD 22.61B 5.25B 2025-12
West Pharmaceutical Services USD 19.8B 932M 2025-12